Redsense Medical Ab Stock Fundamentals
| REDS Stock | SEK 6.30 0.02 0.32% |
Redsense Medical AB fundamentals help investors to digest information that contributes to Redsense Medical's financial success or failures. It also enables traders to predict the movement of Redsense Stock. The fundamental analysis module provides a way to measure Redsense Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Redsense Medical stock.
Redsense |
Redsense Medical AB Company Price To Earning Analysis
Redsense Medical's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Redsense Medical Price To Earning | (50.14) X |
Most of Redsense Medical's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Redsense Medical AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Redsense Medical AB has a Price To Earning of -50.14 times. This is 294.04% lower than that of the Healthcare sector and 237.94% lower than that of the Medical Instruments & Supplies industry. The price to earning for all Sweden stocks is notably higher than that of the company.
Redsense Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Redsense Medical's current stock value. Our valuation model uses many indicators to compare Redsense Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Redsense Medical competition to find correlations between indicators driving Redsense Medical's intrinsic value. More Info.Redsense Medical AB is currently regarded as top stock in price to earning category among its peers. It also is currently regarded as top stock in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Redsense Medical's earnings, one of the primary drivers of an investment's value.Redsense Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Redsense Medical's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Redsense Medical could also be used in its relative valuation, which is a method of valuing Redsense Medical by comparing valuation metrics of similar companies.Redsense Medical is currently under evaluation in price to earning category among its peers.
Redsense Fundamentals
| Price To Earning | (50.14) X | |||
| EBITDA | (6.68 M) | |||
| Net Income | (6.94 M) | |||
| Cash And Equivalents | 3.12 M | |||
| Cash Per Share | 0.28 X | |||
| Total Debt | 3.04 M | |||
| Debt To Equity | 75.30 % | |||
| Current Ratio | 3.43 X | |||
| Book Value Per Share | 0.37 X | |||
| Cash Flow From Operations | (7.09 M) | |||
| Earnings Per Share | (0.63) X | |||
| Beta | 1.25 | |||
| Market Capitalization | 123.97 M | |||
| Z Score | 24.0 |
About Redsense Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Redsense Medical AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Redsense Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Redsense Medical AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Redsense Medical AB provides blood loss detection devices primarily in Europe and the United States. Redsense Medical AB was founded in 2000 and is headquartered in Halmstad, Sweden. Redsense Medical is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Redsense Stock Analysis
When running Redsense Medical's price analysis, check to measure Redsense Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Redsense Medical is operating at the current time. Most of Redsense Medical's value examination focuses on studying past and present price action to predict the probability of Redsense Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Redsense Medical's price. Additionally, you may evaluate how the addition of Redsense Medical to your portfolios can decrease your overall portfolio volatility.